In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator.

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Abstract Text:

C Lee,L Janulis,K Ilio,A Shah,I Park,S Kim,V Cryns,M Pins,R Bergan,

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Publishing Authors By Initials

C Lee,L Janulis,K Ilio,A Shah,I Park,S Kim,V Cryns,M Pins,R Bergan,

For similar neoplasms: neoplasms by site: urogenital neoplasms: genital neoplasms, male: prostatic neoplasms research abstracts see: neoplasms: neoplasms by site: urogenital neoplasms: genital neoplasms, male: prostatic neoplasms research

PUBMED ID PMID:

MEDLINE DATE:

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Journal Published:

PUBLICATION TYPE: Review

Journal: The Prostate. Supplement

VOLUME: 9

Page Numbers: 21-4

Journal Abbreviation:

ISSN: 1050-5881

DAY: 12

MONTH: 02

YEAR: 2000

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Information

Number of References: 39

LANGUAGE: eng

NlmUniqueID: 9003050

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Keywords Mesh Terms:

KEYWORDS: Prostatic Neoplasms

MESH TERMS: pathology

Chemical & Substance for Abstract: In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator. Information

Substance Name: Molecular Chaperones

Registry Number: 0

Grant and Affiliation Information for In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator.

AFFILIATION: Department of Urology, Northwestern University Medical School, Chicago, Illinois 60611, USA.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Prostate Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator Related Publications

• A simple method for determination of the relative function of the right and left lung.
• Anaerobic bacteria as cause of infections in female genital organs.
• Assay of metronidazole by HPLC compared with microbial method.
• Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
• Characterization of enterotoxigenic Escherichia coli. Serotypes, enterotoxins, adhesion fimbriae, and the presence of plasmids.
• Commentary on "sclerotherapy: introduction to solutions and techniques".
• Demonstration of extracellular proteolytic enzymes from Legionella species strains by using synthetic chromogenic peptide substrates.
• Diagnostic considerations and sample collection for anaerobic bacteria.
• Dietary genistein inhibits metastasis of human prostate cancer in mice.
• Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.
• Enterobacteria differentiated by gas-liquid chromatography of metabolites.
• Enzyme activity and protein patterns as premalignant markers in mucosal biopsy specimens from the large intestine.
• Experimental anoxia of the spinal cord and the spastic state.
• Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells.
• In vitro models of prostate apoptosis: clusterin as an antiapoptotic mediator.
• Influence of presensitisation on the fate of cadaveric renal allografts.
• Microbial spectrum and antimicrobial susceptibility in infections after gastrointestinal surgery.
• Neutropenia associated with metronidazole.
• Objective arterial venous examination in peripheral vascular disease.
• Optimisation of azathioprine immunosuppression after organ transplantation by pharmacological measurements.
• Outer membrane proteins and plasmids in different Yersinia enterocolitica serogroups isolated from man and animals.
• Pathogenicity of anaerobic bacteria.
• Portal hypertension due to schistosomiasis.
• Sclerotherapy: a truly minimally invasive technique.
• The methodology used to measure differential gene expression affects the outcome.
• [Carbenicillin--a new penicillin derivative. In vitro effect on Pseudomonas aeruginosa]
• [Mitosis]
• [Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy]
• [Pseudomonas aeruginosa. A pathogenic microbe of current importance]
• [We interview: Frank Bergan, professor, chief physician of Department 3, Ulleval Hospital]